Wedbush analyst David Nierengarten initiated coverage of Nuvalent with an Outperform rating and $39 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NUVL:
Wedbush analyst David Nierengarten initiated coverage of Nuvalent with an Outperform rating and $39 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NUVL: